Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price shot up 1.3% during trading on Wednesday . The stock traded as high as $4.77 and last traded at $4.76. 54,995 shares were traded during trading, an increase of 101% from the average session volume of 27,344 shares. The stock had previously closed at $4.70.
Ono Pharmaceutical Price Performance
The stock has a 50 day moving average of $4.51 and a 200 day moving average of $4.04.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.
In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
